# PUMA BIOTECHNOLOGY, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/puma-biotechnology-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 23 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:20.15485+00:00 | | Last reviewed | 2026-10-17T04:46:20.15485+00:00 | ## Identity - Legal name: PUMA BIOTECHNOLOGY, INC. - Display name: PUMA BIOTECHNOLOGY, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T20:47:06.448656+00:00 | | Completeness | 0.409 | | Record Quality | 0.842 | | Directors | 7 | | Committees | 5 | | Governance events | 16 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Adrian M. Senderowicz, M.D.: Director. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:5 - Alessandra Cesano, M.D., Ph.D.: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:6 - Allison Dorval: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member). claim_id=alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:7 - Brian Stuglik, R.Ph.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:8 - Jay M. Moyes: Director. Status: current. Independent: true. Since: 2012-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:9 - Michael P. Miller: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Compensation (member); Compensation; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:10 - Troy E. Wilson, Ph.D., J.D.: Director. Status: current. Independent: true. Since: 2013-01-01. claim_id=alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:11 ## Committees - Audit (audit). Chair: Jay M. Moyes. Members: Jay M. Moyes (chair, current); Allison Dorval (member, current). committee_id=alpha:committee:puma-biotechnology-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Jay M. Moyes (member, current). committee_id=alpha:committee:puma-biotechnology-inc:audit-chair-compensation - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Jay M. Moyes (member, current); Michael P. Miller (member, current). committee_id=alpha:committee:puma-biotechnology-inc:compensation - Compensation; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Michael P. Miller (member, current). committee_id=alpha:committee:puma-biotechnology-inc:compensation-nominating-and-governance - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Michael P. Miller (member, current). committee_id=alpha:committee:puma-biotechnology-inc:nominating-and-governance ## Executive leadership - Alan H. Auerbach: President, Chief Executive Officer and Chairman of the Board [CEO]. Status: current. claim_id=alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:12 - Douglas Hunt: Chief Regulatory Affairs, Medical Affairs and Pharmacovigilance Officer. Status: current. claim_id=alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:13 - Jeff J. Ludwig: Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:14 - Maximo F. Nougues: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:15 ## Governance events - CEO_CHANGED: Alan H. Auerbach executive of PUMA BIOTECHNOLOGY, INC., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:jcuctqlxi2ba - EXECUTIVE_APPOINTED: Douglas Hunt executive of PUMA BIOTECHNOLOGY, INC., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:1k8kfnpbdj0mp - EXECUTIVE_APPOINTED: Jeff J. Ludwig executive of PUMA BIOTECHNOLOGY, INC., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:13y53f1tkrekt - CFO_CHANGED: Maximo F. Nougues executive of PUMA BIOTECHNOLOGY, INC., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:gosiwyqdsx9e - DIRECTOR_APPOINTED: Alessandra Cesano, M.D., Ph.D. seat on PUMA BIOTECHNOLOGY, INC., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:1aej4m0mvw2v4 - DIRECTOR_APPOINTED: Allison Dorval seat on PUMA BIOTECHNOLOGY, INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:1ayusc41smgxni - COMMITTEE_MEMBER_ADDED: Allison Dorval member of Audit, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:sxlt2z16sj9qp - DIRECTOR_APPOINTED: Brian Stuglik, R.Ph. seat on PUMA BIOTECHNOLOGY, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:1gme3s41ctlg0s - DIRECTOR_APPOINTED: Michael P. Miller seat on PUMA BIOTECHNOLOGY, INC., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:dfxkka1v9n4ye - COMMITTEE_CREATED: Compensation; Nominating and Governance committee of PUMA BIOTECHNOLOGY, INC., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:1pxyi20lob5s2 - COMMITTEE_MEMBER_ADDED: Michael P. Miller member of Compensation; Nominating and Governance, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:tnoigi1894b5c - DIRECTOR_APPOINTED: Adrian M. Senderowicz, M.D. seat on PUMA BIOTECHNOLOGY, INC., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:die7i71oh5axz - DIRECTOR_APPOINTED: Troy E. Wilson, Ph.D., J.D. seat on PUMA BIOTECHNOLOGY, INC., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:hy4fd6n1uiog - DIRECTOR_APPOINTED: Jay M. Moyes seat on PUMA BIOTECHNOLOGY, INC., effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:2b48we17x564g - COMMITTEE_CREATED: Audit · Chair; Compensation committee of PUMA BIOTECHNOLOGY, INC., effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:1mw000mnc8klc - COMMITTEE_MEMBER_ADDED: Jay M. Moyes member of Audit · Chair; Compensation, effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:1sydnom1ra4s20 ## Scoped resources - `alpha://company/puma-biotechnology-inc` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record - `alpha://company/puma-biotechnology-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=identity - `alpha://company/puma-biotechnology-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=corporate-structure - `alpha://company/puma-biotechnology-inc/board` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=board - `alpha://company/puma-biotechnology-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=committees - `alpha://company/puma-biotechnology-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=leadership - `alpha://company/puma-biotechnology-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=ownership - `alpha://company/puma-biotechnology-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=financials - `alpha://company/puma-biotechnology-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=capital-structure - `alpha://company/puma-biotechnology-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=compensation - `alpha://company/puma-biotechnology-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=governance - `alpha://company/puma-biotechnology-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=shareholder-governance - `alpha://company/puma-biotechnology-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=audit - `alpha://company/puma-biotechnology-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=legal - `alpha://company/puma-biotechnology-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=risk - `alpha://company/puma-biotechnology-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=cyber - `alpha://company/puma-biotechnology-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=ai-governance - `alpha://company/puma-biotechnology-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=agents - `alpha://company/puma-biotechnology-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=ecosystem - `alpha://company/puma-biotechnology-inc/events` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=events - `alpha://company/puma-biotechnology-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=relationships - `alpha://company/puma-biotechnology-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=assessments - `alpha://company/puma-biotechnology-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:jay-m-moyes","name":"Jay M. Moyes"},"source_id":"board_seats"}` - Claim alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:allison-dorval","name":"Allison Dorval"},"source_id":"board_seats"}` - Claim alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:jay-m-moyes","name":"Jay M. Moyes"},"source_id":"board_seats"}` - Claim alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:michael-p-miller","name":"Michael P. Miller"},"source_id":"board_seats"}` - Claim alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:michael-p-miller","name":"Michael P. Miller"},"source_id":"board_seats"}` ## Leadership - Adrian M. Senderowicz, M.D.: Director. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:5. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c. - Alessandra Cesano, M.D., Ph.D.: Director. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:6. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c. - Allison Dorval: Director, Audit. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:7. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c. - Brian Stuglik, R.Ph.: Director. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:8. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c. - Jay M. Moyes: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:9. Valid from: 2012-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c. - Michael P. Miller: Director, Compensation; Nominating and Governance. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:10. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c. - Troy E. Wilson, Ph.D., J.D.: Director. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:11. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c. - Alan H. Auerbach: President, Chief Executive Officer and Chairman of the Board. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:12. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8c03f08b0feac396784f5f2734e40180882982f14c6f06eb4fc6773ee20f3f72. - Douglas Hunt: Chief Regulatory Affairs, Medical Affairs and Pharmacovigilance Officer. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:13. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:83caceb8d9eb532756597884e9761a00b2b5d6fe5d4345e13d15fe1fe66c7489. - Jeff J. Ludwig: Chief Commercial Officer. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:14. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1adae5c2302d97ca31f0a28b76c4b291e9f19e33f06d6d0c8bf5e8ae15341be1. - Maximo F. Nougues: Chief Financial Officer. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:15. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:000607ef1ff186b50b02dc30ab3be7e013e54293a62a75b8cff336f71cf8daab. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Jay M. Moyes; Members Jay M. Moyes (Chair); Allison Dorval. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:174a17566c16983b0bf4c35c63bbfb7757f47978853a0282977dad1ba2f0a3f9. - Compensation: Chair not stated; Members Jay M. Moyes; Michael P. Miller. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:174a17566c16983b0bf4c35c63bbfb7757f47978853a0282977dad1ba2f0a3f9. - Nominating and Governance: Chair not stated; Members Michael P. Miller. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:174a17566c16983b0bf4c35c63bbfb7757f47978853a0282977dad1ba2f0a3f9. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - PUMA BIOTECHNOLOGY, INC.. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:48e8181041a3c42858ade4406e5cecd05f0fc457668722ee8d356d888042d40f. ## Entity Status - Public listing published. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:48e8181041a3c42858ade4406e5cecd05f0fc457668722ee8d356d888042d40f. ## Published Fact - US. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:48e8181041a3c42858ade4406e5cecd05f0fc457668722ee8d356d888042d40f. ## Committee Appointment - Jay M. Moyes: chair, Audit. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:174a17566c16983b0bf4c35c63bbfb7757f47978853a0282977dad1ba2f0a3f9. - Allison Dorval: member, Audit. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:174a17566c16983b0bf4c35c63bbfb7757f47978853a0282977dad1ba2f0a3f9. - Jay M. Moyes: member, Compensation. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:174a17566c16983b0bf4c35c63bbfb7757f47978853a0282977dad1ba2f0a3f9. - Michael P. Miller: member, Compensation. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:174a17566c16983b0bf4c35c63bbfb7757f47978853a0282977dad1ba2f0a3f9. - Michael P. Miller: member, Nominating and Governance. Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:174a17566c16983b0bf4c35c63bbfb7757f47978853a0282977dad1ba2f0a3f9. ## Security Listing - PBYI (NASDAQ). Claim: alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:48e8181041a3c42858ade4406e5cecd05f0fc457668722ee8d356d888042d40f. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:48e8181041a3c42858ade4406e5cecd05f0fc457668722ee8d356d888042d40f: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/puma-biotechnology-inc). - alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c: [PUMA BIOTECHNOLOGY, INC. DEF 14A 2025-04-28](https://www.sec.gov/Archives/edgar/data/1401667/000143774925013337/pbyi20250307c_def14a.htm). - alpha:projection-evidence:document:8c03f08b0feac396784f5f2734e40180882982f14c6f06eb4fc6773ee20f3f72: [PBYI DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1401667/000143774926013671/pbyi20260415_def14a.htm). - alpha:projection-evidence:document:83caceb8d9eb532756597884e9761a00b2b5d6fe5d4345e13d15fe1fe66c7489: [PBYI DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1401667/000143774926013671/pbyi20260415_def14a.htm). - alpha:projection-evidence:document:1adae5c2302d97ca31f0a28b76c4b291e9f19e33f06d6d0c8bf5e8ae15341be1: [PBYI DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1401667/000143774926013671/pbyi20260415_def14a.htm). - alpha:projection-evidence:document:000607ef1ff186b50b02dc30ab3be7e013e54293a62a75b8cff336f71cf8daab: [PBYI DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1401667/000143774926013671/pbyi20260415_def14a.htm). - alpha:projection-evidence:174a17566c16983b0bf4c35c63bbfb7757f47978853a0282977dad1ba2f0a3f9: [Audit](https://www.sec.gov/Archives/edgar/data/1401667/000143774925013337/pbyi20250307c_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/puma-biotechnology-inc) - [Public Markdown](https://registry.alpha.ac/companies/puma-biotechnology-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=jsonld) - MCP resource: `alpha://companies/puma-biotechnology-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T20:47:06.22611+00:00; recorded 2026-10-17T20:47:06.22611+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.